I recently had the opportunity to present my organization's experiences with Clinical One Data Collection during a webinar sponsored by Oracle entitled "How to Work with Your CRO to Significantly Improve Clinical Trial Management and the Bottom Line".

As I listened to the challenges facing emerging biopharma, it really hit home, because at Health Decisions, 70% of companies with whom we partner are facing the same issues. I truly understand the frustration that many have expressed in working with other CROs, from the lack of inclusion in selecting an Electronic Data Capture (EDC) system, to extended study build timelines (which directly impact the bottom line costs), to a lack of transparency into processes and a concern over the integrity of the data.

Throughout my career in Data Management and as the Head of Data Management at Health Decisions, I have worked with many EDC platforms. While some are better than others, in the traditional systems, there are still the major pain points surrounding CRF/System development and design, the User Acceptance Testing (UAT) process, post-production updates to the database due to Amendments...the list goes on and on. It was refreshing to know I am not alone in this sentiment, as demonstrated in the results of the webinar polling question below.